Načítá se...
Janus kinase Inhibitors in autoimmune diseases
Biological therapies directed at proinflammatory cytokines have irrevocably changed the landscape of treatment of rheumatoid arthritis (RA) and other autoimmune diseases. With the advances in our knowledge in cytokine signaling, the question emerges whether targeting intracellular signaling might al...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3616338/ https://ncbi.nlm.nih.gov/pubmed/23532440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-202576 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|